Category: Cannabinoid
Cancer Appetite Recovery Study (CAReS) Aptus Clinical, as the full service CRO provider for the Phase 1b/2a Cancer Appetite Recovery Read Now
Selected Partner for Artelo Biosciences Deliver the Upcoming Phase 1B/2A Trial of their Synthetic Cannabinoid, ART27.13 Aptus Clinical has been Read Now
Selected Partner for Artelo Artelo Biosciences Partners for Oncology Trial Artelo Enters into Global R&D Partnership with Syngene International Read Now